Single-center experience with the combination of Cardioplexol™ cardioplegia and MiECC for isolated coronary artery bypass graft procedures

BACKGROUND: Cardioplexol™ with its low volume (100 mL) was originally conceived as cardioplegic solution for MiECC procedures. Introduced in its current form in 2008 in our clinic, it has immediately demonstrated attractive advantages including the easy and rapid administration by the surgeon him/he...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Thorac Dis
Glavni autori: Tevaeara Stahel, Hendrik, Barandun, Silvio, Kaufmann, Emilie, Gahl, Brigitta, Englberger, Lars, Jenni, Hansjoerg, Weber, Alberto, Aymard, Thierry, Gygax, Erich, Carrel, Thierry
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586578/
https://ncbi.nlm.nih.gov/pubmed/31293796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2019.04.47
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items